의약품 위탁개발생산(CDMO) 아웃소싱 시장(2026-2030년)

The global contract development and manufacturing organization outsourcing market is forecasted to grow by USD 179219.6 mn during 2025-2030, accelerating at a CAGR of 17.1% during the forecast period. The report on the global contract development and manufacturing organization outsourcing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising research and development costs associated with pipeline complexity, global explosion of complex biologics and advanced modalities, escalating global burden of chronic diseases and aging demographics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global contract development and manufacturing organization outsourcing market is segmented as below:

By Product

• Small molecules
• Biologics

By Service

• Drug product manufacturing
• API or bulk drugs
• Clinical trial services
• Packaging

By End-User

• Pharmaceutical companies
• Biotechnology companies
• Government and academic research institutes

Geography

• North America
  • US
  • Canada
  • Mexico
• APAC
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Indonesia
• Europe
  • Germany
  • Switzerland
  • France
  • UK
  • Spain
  • The Netherlands
• South America
  • Brazil
  • Argentina
  • Chile
• Middle East and Africa
  • UAE
  • South Africa
  • Egypt
• Rest of World (ROW)

This study identifies the structural transformation and rise of pure-play cdmo models as one of the prime reasons driving the global contract development and manufacturing organization outsourcing market growth during the next few years. Also, technological integration of automated and smart digitized facilities and geographic diversification and onshoring to build supply chain resilience will lead to sizable demand in the market.

The report on the global contract development and manufacturing organization outsourcing market covers the following areas:

• Global contract development and manufacturing organization outsourcing market sizing
• Global contract development and manufacturing organization outsourcing market forecast
• Global contract development and manufacturing organization outsourcing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global contract development and manufacturing organization outsourcing market vendors that include Aenova Holding GmbH, Alcami Corp, Bora Pharmaceuticals, Cambrex Corp., Catalent Inc., Charles River Laboratories, Delpharm, Eurofins Scientific SE, Evonik Industries AG, Fujifilm Diosynth Biotechnologies, Gerresheimer AG, Hovione S.A., Laboratory Holdings Inc., NextPharma GmbH, Piramal Pharma Solutions, Samsung Biologics Co. Ltd., Thermo Fisher Scientific Inc., Vetter Pharma Fertigung GmbH, WuXi AppTec Co. Ltd., WuXi Biologics Cayman Inc.. Also, the global contract development and manufacturing organization outsourcing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Service
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Contract Development And Manufacturing Organization Outsourcing Market 2020 - 2024
  • Historic Market Size - Data Table on Global Contract Development And Manufacturing Organization Outsourcing Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 Service segment analysis 2020 - 2024
  • Historic Market Size - Service Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global contract development and manufacturing organization outsourcing market
• 6.2 Impact of geopolitical conflicts on global contract development and manufacturing organization outsourcing market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Small molecules - Market size and forecast 2025-2030
• 8.4 Biologics - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Service

• 9.1 Market segments
• 9.2 Comparison by Service
• 9.3 Drug product manufacturing - Market size and forecast 2025-2030
• 9.4 API or bulk drugs - Market size and forecast 2025-2030
• 9.5 Clinical trial services - Market size and forecast 2025-2030
• 9.6 Packaging - Market size and forecast 2025-2030
• 9.7 Market opportunity by Service
  • Market opportunity by Service ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Pharmaceutical companies - Market size and forecast 2025-2030
• 10.4 Biotechnology companies - Market size and forecast 2025-2030
• 10.5 Government and academic research institutes - Market size and forecast 2025-2030
• 10.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 APAC - Market size and forecast 2025-2030
  • 12.4.1 China - Market size and forecast 2025-2030
  • 12.4.2 India - Market size and forecast 2025-2030
  • 12.4.3 South Korea - Market size and forecast 2025-2030
  • 12.4.4 Japan - Market size and forecast 2025-2030
  • 12.4.5 Australia - Market size and forecast 2025-2030
  • 12.4.6 Indonesia - Market size and forecast 2025-2030
• 12.5 Europe - Market size and forecast 2025-2030
  • 12.5.1 Germany - Market size and forecast 2025-2030
  • 12.5.2 Switzerland - Market size and forecast 2025-2030
  • 12.5.3 France - Market size and forecast 2025-2030
  • 12.5.4 UK - Market size and forecast 2025-2030
  • 12.5.5 Spain - Market size and forecast 2025-2030
  • 12.5.6 The Netherlands - Market size and forecast 2025-2030
• 12.6 South America - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Argentina - Market size and forecast 2025-2030
  • 12.6.3 Chile - Market size and forecast 2025-2030
• 12.7 Middle East and Africa - Market size and forecast 2025-2030
  • 12.7.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.7.2 UAE - Market size and forecast 2025-2030
  • 12.7.3 South Africa - Market size and forecast 2025-2030
  • 12.7.4 Egypt - Market size and forecast 2025-2030
  • 12.7.5 Nigeria - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising research and development costs associated with pipeline complexity
  • Global explosion of complex biologics and advanced modalities
  • Escalating global burden of chronic diseases and aging demographics
• 13.2 Market challenges
  • High capital expenditure requirements and technical barriers to entry
  • Overwhelming complexity in stringent regional regulatory compliance
  • Critical capacity constraints and global supply chain disruptions
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Structural transformation and rise of pure-play CDMO models
  • Technological integration of automated and smart digitized facilities
  • Geographic diversification and onshoring to build supply chain resilience

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Aenova Holding GmbH
  • Aenova Holding GmbH - Overview
  • Aenova Holding GmbH - Product / Service
  • Aenova Holding GmbH - Key offerings
  • SWOT
• 15.5 Bora Pharmaceuticals
  • Bora Pharmaceuticals - Overview
  • Bora Pharmaceuticals - Product / Service
  • Bora Pharmaceuticals - Key offerings
  • SWOT
• 15.6 Cambrex Corp.
  • Cambrex Corp. - Overview
  • Cambrex Corp. - Product / Service
  • Cambrex Corp. - Key offerings
  • SWOT
• 15.7 Catalent Inc.
  • Catalent Inc. - Overview
  • Catalent Inc. - Product / Service
  • Catalent Inc. - Key offerings
  • SWOT
• 15.8 Charles River Laboratories
  • Charles River Laboratories - Overview
  • Charles River Laboratories - Business segments
  • Charles River Laboratories - Key offerings
  • Charles River Laboratories - Segment focus
  • SWOT
• 15.9 Eurofins Scientific SE
  • Eurofins Scientific SE - Overview
  • Eurofins Scientific SE - Business segments
  • Eurofins Scientific SE - Key offerings
  • Eurofins Scientific SE - Segment focus
  • SWOT
• 15.10 Evonik Industries AG
  • Evonik Industries AG - Overview
  • Evonik Industries AG - Business segments
  • Evonik Industries AG - Key offerings
  • Evonik Industries AG - Segment focus
  • SWOT
• 15.11 Gerresheimer AG
  • Gerresheimer AG - Overview
  • Gerresheimer AG - Business segments
  • Gerresheimer AG - Key offerings
  • Gerresheimer AG - Segment focus
  • SWOT
• 15.12 Laboratory Holdings Inc.
  • Laboratory Holdings Inc. - Overview
  • Laboratory Holdings Inc. - Business segments
  • Laboratory Holdings Inc. - Key offerings
  • Laboratory Holdings Inc. - Segment focus
  • SWOT
• 15.13 NextPharma GmbH
  • NextPharma GmbH - Overview
  • NextPharma GmbH - Product / Service
  • NextPharma GmbH - Key offerings
  • SWOT
• 15.14 Samsung Biologics Co. Ltd.
  • Samsung Biologics Co. Ltd. - Overview
  • Samsung Biologics Co. Ltd. - Product / Service
  • Samsung Biologics Co. Ltd. - Key offerings
  • SWOT
• 15.15 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 15.16 Vetter Pharma Fertigung GmbH
  • Vetter Pharma Fertigung GmbH - Overview
  • Vetter Pharma Fertigung GmbH - Product / Service
  • Vetter Pharma Fertigung GmbH - Key offerings
  • SWOT
• 15.17 WuXi AppTec Co. Ltd.
  • WuXi AppTec Co. Ltd. - Overview
  • WuXi AppTec Co. Ltd. - Business segments
  • WuXi AppTec Co. Ltd. - Key offerings
  • WuXi AppTec Co. Ltd. - Segment focus
  • SWOT
• 15.18 WuXi Biologics Cayman Inc.
  • WuXi Biologics Cayman Inc. - Overview
  • WuXi Biologics Cayman Inc. - Product / Service
  • WuXi Biologics Cayman Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations